Literature DB >> 29034584

Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.

Michelle L Ratay1, Elena Bellotti2, Riccardo Gottardi3, Steven R Little4.   

Abstract

Dry eye disease, age-related macular degeneration, and uveitis are ocular diseases that significantly affect the quality of life of millions of people each year. In these diseases, the action of chemokines, proinflammatory cytokines, and immune cells drives a local inflammatory response that results in ocular tissue damage. Multiple therapeutic strategies are developed to either address the symptoms or abate the underlying cause of these diseases. Herein, the challenges to deliver drugs to the relevant location in the eye for each of these diseases are reviewed along with current and innovative therapeutic approaches that attempt to restore homeostasis within the ocular microenvironment.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  age-related macular degeneration; drug delivery; dry eye disease; therapeutics; uveitis

Mesh:

Substances:

Year:  2017        PMID: 29034584      PMCID: PMC5915344          DOI: 10.1002/adhm.201700733

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  240 in total

1.  Mechanism of nanocapsules formation by the emulsion-diffusion process.

Authors:  Delphine Moinard-Chécot; Yves Chevalier; Stéphanie Briançon; Laurent Beney; Hatem Fessi
Journal:  J Colloid Interface Sci       Date:  2007-10-03       Impact factor: 8.128

Review 2.  Current and future ophthalmic drug delivery systems. A shift to the posterior segment.

Authors:  Eva M Del Amo; Arto Urtti
Journal:  Drug Discov Today       Date:  2008-01-08       Impact factor: 7.851

Review 3.  Biodegradable polymeric nanoparticles based drug delivery systems.

Authors:  Avnesh Kumari; Sudesh Kumar Yadav; Subhash C Yadav
Journal:  Colloids Surf B Biointerfaces       Date:  2009-09-08       Impact factor: 5.268

4.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

5.  Doxycycline's effect on ocular angiogenesis: an in vivo analysis.

Authors:  Constance A Cox; Juan Amaral; Rita Salloum; Liliana Guedez; Ted W Reid; Cindy Jaworski; Moly John-Aryankalayil; Ken A Freedman; Mercedes M Campos; Alfredo Martinez; Susan P Becerra; Deborah A Carper
Journal:  Ophthalmology       Date:  2010-06-03       Impact factor: 12.079

Review 6.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

Review 7.  Ocular delivery of macromolecules.

Authors:  Yoo Chun Kim; Bryce Chiang; Xianggen Wu; Mark R Prausnitz
Journal:  J Control Release       Date:  2014-07-03       Impact factor: 9.776

8.  Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model.

Authors:  Zhen Zhang; Wen-Zhao Yang; Zhen-Zhen Zhu; Qian-Qian Hu; Yan-Feng Chen; Hui He; Yong-Xiong Chen; Zu-Guo Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-06       Impact factor: 4.799

9.  Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model.

Authors:  Achim H Krauss; Rosa M Corrales; Flavia S A Pelegrino; Johanna Tukler-Henriksson; Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

10.  Clinical outcomes of cyclosporine treatment for noninfectious uveitis.

Authors:  Sun Ho Lee; Hum Chung; Hyeong Gon Yu
Journal:  Korean J Ophthalmol       Date:  2012-01-14
View more
  3 in total

Review 1.  Recent advances of exosomes in immune-mediated eye diseases.

Authors:  Na Li; Lu Zhao; Yankai Wei; Vicki L Ea; Hong Nian; Ruihua Wei
Journal:  Stem Cell Res Ther       Date:  2019-08-30       Impact factor: 6.832

Review 2.  Harnessing Endogenous Stimuli for Responsive Materials in Theranostics.

Authors:  Alexander B Cook; Paolo Decuzzi
Journal:  ACS Nano       Date:  2021-02-08       Impact factor: 15.881

3.  High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit.

Authors:  Xinxin Yu; Renshu Zhang; Lei Lei; Qianqian Song; Xingyi Li
Journal:  Int J Nanomedicine       Date:  2019-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.